Agoraphobia and Medical Cannabis: The Facts
of people will experience agoraphobia in their lifetime [1]
such as agoraphobia are the most common mental health disorders in the world [2]
What Causes Agoraphobia?
There is no single cause. In most cases, several factors come together. These can include:
- Traumatic or distressing experiences during childhood or adolescence.
- Stressful life events in adulthood, such as bereavement, divorce or losing a job.
- A history of other mental health conditions, including depression or eating disorders such as anorexia nervosa or bulimia nervosa.
- Panic disorder — around one in three people living with panic disorder may also develop agoraphobia.
- Alcohol or substance misuse.
- Difficult personal relationships, particularly those involving conflict or control.
What are the Symptoms of Agoraphobia?
Agoraphobia is built around fear of situations that feel hard to escape, or where help may not be there if anxiety or panic builds. This fear shapes how people behave day to day.
Common behaviours can include:
- Avoiding crowded places or social situations
- Staying at home or in a familiar ‘safe’ space
- Feeling unable to leave the house without a trusted person
- Avoiding travelling alone or going far from home
- Feeling anxious in shops, queues, or on public transport
- Physical and emotional symptoms of anxiety or panic can include:
- A racing heartbeat or shortness of breath
- Excessive sweating
- Feeling sick
- Chest pain or tightness
- Stomach discomfort, such as churning or diarrhoea
- Dizziness, light-headedness, or feeling faint
- Shaking or trembling
- Difficulty swallowing
- Ringing in the ears
- Feeling detached, overwhelmed, or fearful of losing control
How is Agoraphobia Diagnosed?
Agoraphobia is usually diagnosed by a GP. The first step is a conversation about your symptoms, how they affect daily life, and any history of mental health conditions. You may be referred to a psychiatrist or specialist mental health team for further assessment and support.
A diagnosis is based on strong fear or anxiety in at least two of the following situations:
- Using public transport
- Being in open spaces
- Visiting places such as shops, theatres, or cinemas
- Standing in queues or being in crowded environments
- Being outside the home alone
How strongly these situations are avoided, and how much distress they cause, both contribute to the diagnosis.
Treatment Options for Agoraphobia
Agoraphobia can be hard to manage alone, but several treatments work well.
Talking therapies are usually the first step.
These include:
- Cognitive behavioural therapy (CBT)
- Exposure therapy, which helps individuals gradually face feared situations in a safe and controlled way
Healthcare professionals may also suggest changes that can support symptom management, such as:
- Regular physical activity
- A balanced, healthy diet
- Cutting down on alcohol, as it can make symptoms worse over time
- Limiting caffeine intake from items such as coffee, tea, and fizzy drinks
If symptoms persist or are more severe, medication may be considered. This can include:
- Anti-anxiety (anxiolytic) medications
- Antidepressants
For some patients, medical cannabis may be considered as part of a personalised treatment plan, depending on individual circumstances and specialist clinical advice.
How does Agoraphobia Affect People?
Living with agoraphobia can affect much more than where you go. Over time, it can shape independence, work, relationships, and overall quality of life.
Many people gradually change their routines to avoid the situations that trigger their anxiety. That might mean turning down social invitations, avoiding busy environments, leaning on loved ones for support, or feeling unable to travel alone. Everyday tasks – shopping, attending appointments, commuting – can become exhausting.
These experiences can lead to frustration, loneliness, or low mood, particularly when agoraphobia begins to affect relationships, work, or social confidence. The emotional impact can be just as significant as the physical symptoms.
With the right support and treatment, many people manage their symptoms well and steadily rebuild their confidence. Because everyone’s experience is different, treatment plans are usually tailored to the individual.
Medical Cannabis for Agoraphobia
Medical cannabis has been legal in the UK since November 2018. It is rarely available through the NHS, so most patients access treatment via a specialist private clinic.
Medical cannabis is usually only considered after first-line treatments – such as talking therapies and conventional medicines – have not provided enough relief, or have caused difficult side effects. It is not a cure for agoraphobia, and any decision to consider medical cannabis is made on a case-by-case basis by a specialist clinician as part of a wider, individualised treatment plan.
Medical cannabis is not suitable for everyone. A specialist clinician weighs up the benefits and risks for each person before deciding whether to prescribe.
Research Regarding Medical Cannabis and Agoraphobia
Research specifically exploring medical cannabis and agoraphobia remains limited. However, some studies have investigated the potential role of medical cannabis in anxiety-related conditions that may share similar symptoms or experiences.
The UK Medical Cannabis Registry, which collects data from patients prescribed medical cannabis, has reported changes in symptoms among patients living with generalised anxiety disorder (GAD). Patients in the registry were prescribed a range of medical cannabis products, including oils and dried flower for vaporisation.
The case series reported changes in patient-reported anxiety severity and quality of life scores during the observation period. As this was an observational study, no causal inference can be drawn between medical cannabis and any observed changes. Real-world data of this kind can help researchers understand patterns in clinical practice, and points to the need for further high-quality clinical trials.
What are the Side Effects of Medical Cannabis for Agoraphobia and other GADs?
As with any medicine, medical cannabis may cause side effects in some patients. These can vary depending on the person, the formulation, and the dose. Some side effects may be serious.
Data from the UK Medical Cannabis Registry found that some patients prescribed medical cannabis for anxiety-related conditions reported side effects, with the most commonly reported including dry mouth and difficulty concentrating. A specialist clinician will discuss the potential risks and benefits with each patient before making any prescribing decision.
Can I be Prescribed Medical Cannabis for Agoraphobia?
In the UK, medical cannabis is an unlicensed medicine. It can only be initiated by a specialist doctor on the GMC Specialist Register, and only when licensed treatments have not produced an acceptable outcome for the individual patient. Any prescribing decision is taken on a case-by-case basis after a full clinical assessment.
To find out whether a specialist consultation may be appropriate for you, complete an initial eligibility assessment with Curaleaf Clinic. The team will review your medical history and specialist records. If you meet the criteria for assessment, you will be invited to speak with a consultant experienced in anxiety disorders.
References
[1] Roest AM, de Vries YA, Lim CCW, Wittchen HU, Stein DJ, Adamowski T, et al. A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys. Depress Anxiety. 2019;36:499–510. doi: 10.1002/da.22885.
[2] World Health Organization (2025). Anxiety disorders. Available at: https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders.
[3] Li, A., Erridge, S., Holvey, C., Coomber, R., Barros, D., Bhoskar, U., Crews, M., Donnelly, L., Imran, M., Korb, L., Mwimba, G., Sachdeva-Mohan, S., Rucker, J. J., & Sodergren, M. H. (2024). UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. International clinical psychopharmacology, 39(6), 350–360. https://doi.org/10.1097/YIC.0000000000000536